Commonwealth Equity Services
INTS icon

Commonwealth Equity Services’s Intensity Therapeutics INTS Stock Holding History

Commonwealth Equity Services’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-417
Closed -$40K – 4155
2024
Q3 		$40K Hold
417
– – ﹤0.01% 3954
2024
Q2 		$51K Hold
417
– – ﹤0.01% 3893
2024
Q1 		$54K Buy
+417
New +$50K ﹤0.01% 3882

Other funds holding INTS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
OCPWS
One Charles Private Wealth Services Hingham, Massachusetts $434M AUM 22.37% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.18B AUM 18.43% 1-Year Est. Return

Commonwealth Equity Services's INTS Position: Q4 2024 in Review

Commonwealth Equity Services sold out of Intensity Therapeutics (INTS) in Q4 2024, closing a stake of 417 shares — an estimated $40K sold.

Commonwealth Equity Services first reported a position in INTS in Q1 2024 and held it in 3 quarters. The position peaked at $54K in Q1 2024. 20 funds tracked by Wall St. Rank hold INTS as of Q4 2024.

  • Commonwealth Equity Services reported no remaining Intensity Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 417 Intensity Therapeutics shares in Q4 2024, an estimated $40K.
  • Commonwealth Equity Services first reported a position in Intensity Therapeutics in Q1 2024 and held it in 3 quarters.
  • Commonwealth Equity Services's Intensity Therapeutics position peaked at $54K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q4 2024.

Based on Commonwealth Equity Services's 13F filing for Q4 2024, filed 10 Feb 2025.